Age and d PCR can predict relapse in CML patients who discontinued imatinib: The ISAV study

Imatinib is effective for the treatment of chronic myeloid leukemia (CML). However even undetectable BCR‐ABL1 by Q‐RT‐PCR does not equate to eradication of the disease. Digital‐PCR (dPCR), able to detect 1 BCR‐ABL1 positive cell out of 10 7 , has been recently developed. The ISAV study is a multicen...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	American journal of hematology 2015-10, Vol.90 (10), p.910-914
Hauptverfasser:	Mori, Silvia, Vagge, Elisabetta, le Coutre, Philipp, Abruzzese, Elisabetta, Martino, Bruno, Pungolino, Ester, Elena, Chiara, Pierri, Ivana, Assouline, Sarit, D'Emilio, Anna, Gozzini, Antonella, Giraldo, Pilar, Stagno, Fabio, Iurlo, Alessandra, Luciani, Michela, De Riso, Giulia, Redaelli, Sara, Kim, Dong‐Wook, Pirola, Alessandra, Mezzatesta, Caterina, Petroccione, Anna, Lodolo D'Oria, Agnese, Crivori, Patrizia, Piazza, Rocco, Gambacorti‐Passerini, Carlo
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!